On the recordDecember 14, 2023
Last year, three major insulin companies announced that they would limit the cost of insulin to $35 a month for all patients.
Source
congress.govEditor's note · Context
Hassan discusses recent insulin pricing commitments by major companies.
Share
More from Maggie Hassan
Jul 10, 2026
This bill expands a partisan slush fund for ICE, allows the President to continue his extravagant golden ballroom project, and paves the way for the President to roll out his $1.8 billion taxpayer-funded giveaway to January 6…
Jun 19, 2026
For too long, Big Pharma has been abusing the patent process to block generic competition and keep drug prices for patients artificially high.
Jul 14, 2026
The bipartisan 21st Century ROAD to Housing Act that I fought for will help more communities build homes like these, and I look forward to it becoming law at midnight— despite President Trump’s tantrum about it.
Jun 19, 2026
My bipartisan bills crack down on Big Pharma and make it easier for families to access lower-cost generic medications.
Other voices in this conversation
